YGEN.L Share News (YGEN)

Novacyt completes buy of molecular diagnostics firm Yourgene Health

(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is complete.

TRADING UPDATES: Tintra receives bid approach; NCC trading in line

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM

(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series.

IN BRIEF: Novacyt takeover of Yourgene Health closer to completion

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by Novacyt SA has been approved by shareholders at a court and general meeting. Around 99% of shareholders who voted were in favour of the scheme. Takeover now requires the scheme of arrangement to be court sanctioned. These timings will be provided in due course.

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Ithaca encouraged by K2; Safestyle profit warning

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Yourgene Health inks five-year, Illumina contract extension

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for Yourgene's sequencing based NIPT in vitro diagnostic products, which will now run until September 2028. Says the license allows it to continue its product development roadmaps, as it looks to further move into "key international markets, such as the Americas, UK, Europe and Australia.

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors.

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Yourgene Health agrees to GBP17 million acquisition offer from Novacyt

(Alliance News) - Yourgene Health PLC on Monday said it has agreed to a cash takeover offer from Novacyt SA that values Yourgene about GBP17 million.

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

Novacyt to buy Yourgene Health in £16.7m deal

(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.

Yourgene Health shares rise on sale of Taiwan subsidiary

(Alliance News) - Yourgene Health PLC on Tuesday said it will sell its subsidiary Yourgene Health Taiwan Co Ltd to INEX Innovate Pte Ltd for up to USD4 million

Yourgene to process tests at lab as part of MyHealthChecked Boots deal

(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd.

TRADING UPDATES: Yourgene Health sees revenue above market forecasts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: